Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
31.7%
% of MNTL's 44 holdings also in IBRN
32.5%
% of IBRN's 58 holdings also in MNTL
Overlap by Weight
Sector Drift (MNTL minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MNTL |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
ARGENX SE ADR | 5.6% | 5.0% | 5.0% |
 |
NEUROCRINE BIOSCIENCES INC | 4.2% | 4.5% | 4.2% |
|
BIOGEN IDEC INC | 3.1% | 3.9% | 3.1% |
|
CATALYST PHARMACEUTICAL PART | 2.7% | 5.1% | 2.7% |
|
DENALI THERAPEUTICS INC. | 2.0% | 3.8% | 2.0% |
Position Highlights (Non-Overlapping Exposures)
MNTL Overweight Relative to IBRN
|
VERTEX PHARMACEUTICALS INC | 11.9% |
|
REGENERON PHARMACEUTICALS | 7.7% |
|
ALNYLAM PHARMACEUTICALS INC | 4.9% |
|
ELI LILLY & CO | 4.9% |
|
CRINETICS PHARMACEUTICALS INC | 4.2% |
 |
TEVA PHARMACEUTICAL-SP ADR | 4.2% |
|
STRYKER CORP | 2.9% |
 |
MEDTRONIC PLC | 2.6% |
|
AXSOME THERAPEUTICS, INC. | 2.6% |
|
IONIS PHARMACEUTICALS, INC. | 2.5% |
MNTL Underweight Relative to IBRN
 |
SK BIOPHARMACEUTICALS CO., LTD. | -5.0% |
|
SUPERNUS PHARMACEUTICALS INC | -4.2% |
|
PTC THERAPEUTICS INC | -2.9% |
|
SCHOLAR ROCK HOLDING CORP. | -2.7% |
|
INTEGRA LIFESCIENCES HOLDING | -2.7% |
|
ACADIA PHARMACEUTICALS INC | -2.5% |
|
CATALYST PHARMACEUTICAL PART | -2.4% |
|
EDGEWISE THERAPEUTICS, INC. | -2.3% |
|
ALKERMES PLC | -2.2% |
 |
SANBIO CO., LTD. | -2.1% |